Partnership Opportunities

Our 2024 partners tapped into the exciting opportunities emerging in the nasal drug delivery space!

With biopharma’s nasal delivery pipelines advancing across various drug products and first FDA approvals in neurological conditions, vaccines, and allergy, our partners were able to remain at the forefront of the booming intranasal drug delivery industry.

The 2nd Novel Nasal Formulation & Delivery Summit was your exclusive platform to engage with industry leaders, understand their challenges, and showcase your innovative solutions.

Our 2024 speaker faculty boasts C-level executives, industry experts, and scientists from the likes of Neurelis, Sanofi, Genetech, Ocugen, and Lumen Bio.

Offering numerous interactive and networking sessions, focusing on critical areas such as analytics, particle engineering, and device compatibility. Our 2024 partners had direct access to decision-makers who are actively seeking solutions for their projects.

This was your opportunity to position your company as a key player in the nascent and rapidly growing nasal drug delivery market.

What You Missed:

  Align with market trends, new approaches, and industry demands to perfectly meet leading biopharma’s future needs and generate opportunities.
  Forge new connections with KOLs and decision-makers in nasal drug delivery across vaccines, respiratory, allergy, and neurological indications and more.
  Gain exclusive branding exposure, showcasing your technologies to a highly targeted audience looking for bespoke particle, analytical, and device solutions.

Experts Need Your Help With:

  Practical Engineering & Characterization
Formulation Development
Device Provision
Equipment Including Freeze Drying 
Preclinical Model Development

Who Attendees Met?

2270042101

Based on 2023's Novel Nasal Formulation & Delivery Summit